The Asia-Pacific's growing and maturing sector of biopharmaceutical industry offers tremendous business and investment opportunities. China, India, Australia, Taiwan South Korea and Japan have already established themselves as serious players, committing significant amounts to investment in the next five to ten years to strengthen their capabilities. The level of mergers and acquisitions (M&A) is expected to pick up and the investors can expect a wave of cross-border consolidations and initial public offerings (IPOs).
In light of the growing interest in Asia's R&D opportunities, we have compiled an ebook showcasing Asia's 20 most promising biotech companies who are looking for partners and investors to assist them in their funding and co-development needs.
- Promising biotechs in Australia, China, Japan, Korea, Taiwan, India, Israel
- Their pipelines
- Various partnership and investment opportunities
At BioPharma Asia Convention 2014, we aim to create the leading platform in Asia for biopharmaceutical stakeholders in Asia and beyond to tap on the growth potential in the Asian biopharmaceutical market through partnerships.